Companies: 10,795·Total market cap: $144.5T
Benitec Biopharma Inc.

Benitec Biopharma Inc.

BNTCNASDAQHealthcare● Active
$10.50
$-0.05(-0.47%)
Market Cap$275593983
P/E Ratio—
52W High$17.15
52W Low$9.85
Overview

Benitec Biopharma Inc. (BNTC) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001808898 · BNTC · NASDAQ · as of Jun 8, 2026

Filing snapshot

320
Total Filings
8-K
Latest Form
2026-05-29
Most Recent
2014
Filing Since
FinancialsEarningsView All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0001808898 · Updated hourly · Not investment advice

Latest Annual Report

10-K · Annual ReportFY
Filed Date
2026-03-20
Fiscal Year End
Mar 20, 2026
Accession No.
0001193125-26-117604
Primary Document
d226768d10ka.htm
View on SEC EDGARDownload PDFFiling Index
Source: data.sec.gov · CIK 0001808898 · Accession 0001193125-26-117604

Latest Key Filings

10-QQuarterly Report
10-Q
2026-05-14
View 10-Q on SEC
8-KCurrent Report
8-K
2026-05-29Material Event
View 8-K on SEC
Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144
8-KCurrent Report
8-K
2026-05-29
View
3Initial Statement of Beneficial Ownership
3
2026-05-28
View
10-QQuarterly Report
10-Q
2026-05-14
View
8-KCurrent Report
8-K
2026-05-14
View
10-K/AAnnual Report (Amended)
10-K/A
2026-03-20
View
8-KCurrent Report
8-K
2026-02-12
View
10-QQuarterly Report
10-Q
2026-02-12
View
424B3424B3
424B3
2026-02-11
View
EFFECTEFFECT
EFFECT
2026-02-10
View
CORRESPCORRESP
CORRESP
2026-02-06
View
UPLOADUPLOAD
UPLOAD
2026-02-06
View
S-3Shelf Registration
S-3
2026-01-30
View
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2026-01-29
View
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2025-12-08
View
SCHEDULE 13GSCHEDULE 13G
SCHEDULE 13G
2025-12-03
View
Showing 1–15 of 271 filingsForm 4 / 144 hidden· 320 total in EDGAR

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001808898  |  Exchange: NASDAQ · Healthcare

Benitec Biopharma Inc. (NASDAQ: BNTC) has submitted 320 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2014. As a Healthcare sector company with CIK 0001808898, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is Benitec Biopharma Inc.'s most comprehensive regulatory disclosure. The most recent Benitec Biopharma Inc. 10-K was filed on 2026-03-20 for fiscal year ending 2026. Historical BNTC 10-K annual reports are available from 2020 through 2026.

Investors researching Benitec Biopharma Inc. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-08
Related Companies SEC Filings — Healthcare
XOMA SEC Filings →SLDB SEC Filings →NGNE SEC Filings →OCGN SEC Filings →PRTC SEC Filings →AUTL SEC Filings →LCTX SEC Filings →IMAB SEC Filings →
→ BNTC Financials→ BNTC Earnings→ BNTC Insider Trades

Frequently Asked Questions

BNTC SEC Filings · 8 questions

Benitec Biopharma Inc. (BNTC) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 320 filings and access original documents at no cost. Benitec Biopharma Inc.'s CIK is 0001808898.

BNTC SEC filingsBenitec Biopharma Inc. SEC documentsfind BNTC 10-K